More on VKTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $27.37 |
|
|||
| Open | $27.17 | ||||
| 52 Wk High | $5.17 | ||||
| 52 Wk Low | $0.94 | ||||
| Day High | $27.35 | ||||
| Day Low | $24.94 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 7,581,989 | ||||
- UBS Starts Viking Therapeutic (VKTX) at Buy
- Viking Therapeutics starts Phase 3 trials for oral obesity drug VK2735
- Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity
- Viking Therapeutic (VKTX) PT Lowered to $85 at Truist Securities
- Viking Therapeutics starts oral VK2735 maintenance dosing trial
- Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
- Form 8-K Viking Therapeutics, For: Sep 23
- Viking Therapeutics raises $575M through stock and note offerings
- Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Co
- Form 424B5 Viking Therapeutics,
Entities mentioned with VKTX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- William Blair | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
